The encryption fintech company Antalpha saw a big pump of 70% on its first day of trading on the US stock market, triggering a circuit breaker.

GateUser-6433627c · 2025-05-14T21:03:21+00:00

Antalpha's initial public offering (IPO) is priced at $12.80 per share of common stock, with plans to list on Nasdaq under the ticker symbol "ANTA." The company is a cryptocurrency financial technology enterprise focused on providing financial services to Bitcoin miners and has become a major lending partner of Bitmain. After the stock is listed, Antalpha's share price rises to $22.2, with a daily increase of up to 73.59%, triggering a trading halt.

GateUser-6433627c

2025-05-14 21:03:21

Abstract generation in progress

On May 14, GlobeNewswire reported that Antalpha Platform Holding Company (“Antalpha”) today announced that its initial public offering (IPO) was priced at $12.80 per common share for a total of 3,850,000 common shares. The Company’s common stock has been approved for listing on the Nasdaq Global Market and is expected to begin trading on May 14, 2025 under the ticker symbol “ANTA.” The offering is expected to close on May 15, 2025, subject to customary closing conditions. It is reported that Antalpha is a crypto fintech company focused on providing liquidity and risk management solutions for institutional Bitcoin miners. As Bitmain’s primary lending partner, Antalpha provides supply chain lending and margin lending services through its Antalpha Prime technology platform, enabling customers to initiate and manage digital asset loans while monitoring collateral positions with near-real-time data. According to market data, as of press time, Antalpha (ANTA) shares have risen to $22.2, an intraday increase of 73.59%, triggering an intraday circuit breaker.

BTC-2,14%

PRIME-3,54%

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.